AKT1 and lung carcinoma: Figure 3 showed the anticancer activity of EGCG against lung cancer via immune modulation, apoptosis induction, inhibition of metastasis, angiogenesis, and cell proliferation, improved antioxidant capacity, and downregulating MMPs, VEGF, and the Wnt/P13K/Akt axis.